Literature DB >> 14680701

Efficient switching of mycobacteriophage L5-based integrating plasmids in Mycobacterium tuberculosis.

Carey A Pashley1, Tanya Parish.   

Abstract

We previously used a mycobacteriophage L5-derived integrating vector to demonstrate that glnE and aroK are essential genes in Mycobacterium tuberculosis by showing that we were unable to excise the integrated vector when it carried the only functional copy of these genes. We tested three systems to replace the integrated copy with alternative alleles. The most efficient method was to transform the strain with a second copy of the integrating vector. Excision of the resident vector and integration of the incoming vector occurred at an extremely high efficiency. This technique will allow us to study the role and functionality of essential genes in this important human pathogen.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14680701     DOI: 10.1016/S0378-1097(03)00823-1

Source DB:  PubMed          Journal:  FEMS Microbiol Lett        ISSN: 0378-1097            Impact factor:   2.742


  52 in total

1.  Phage L5 integrating vectors are present within the Mycobacterial Cell in an equilibrium between integrated and excised states.

Authors:  Beatrice Saviola
Journal:  Cancer Ther       Date:  2009-01

2.  The nonmevalonate pathway of isoprenoid biosynthesis in Mycobacterium tuberculosis is essential and transcriptionally regulated by Dxs.

Authors:  Amanda C Brown; Matthias Eberl; Dean C Crick; Hassan Jomaa; Tanya Parish
Journal:  J Bacteriol       Date:  2010-02-19       Impact factor: 3.490

3.  Glyoxylate detoxification is an essential function of malate synthase required for carbon assimilation in Mycobacterium tuberculosis.

Authors:  Susan Puckett; Carolina Trujillo; Zhe Wang; Hyungjin Eoh; Thomas R Ioerger; Inna Krieger; James Sacchettini; Dirk Schnappinger; Kyu Y Rhee; Sabine Ehrt
Journal:  Proc Natl Acad Sci U S A       Date:  2017-03-06       Impact factor: 11.205

4.  UvrD2 is essential in Mycobacterium tuberculosis, but its helicase activity is not required.

Authors:  Alan Williams; Carolin Güthlein; Nicola Beresford; Erik C Böttger; Burkhard Springer; Elaine O Davis
Journal:  J Bacteriol       Date:  2011-07-01       Impact factor: 3.490

5.  Phosphorylation on PstP Regulates Cell Wall Metabolism and Antibiotic Tolerance in Mycobacterium smegmatis.

Authors:  Farah Shamma; Kadamba Papavinasasundaram; Samantha Y Quintanilla; Aditya Bandekar; Christopher Sassetti; Cara C Boutte
Journal:  J Bacteriol       Date:  2021-01-25       Impact factor: 3.490

6.  Inhibition of the sole type I signal peptidase of Mycobacterium tuberculosis is bactericidal under replicating and nonreplicating conditions.

Authors:  J Ollinger; T O'Malley; J Ahn; J Odingo; T Parish
Journal:  J Bacteriol       Date:  2012-03-16       Impact factor: 3.490

7.  Interaction of CarD with RNA polymerase mediates Mycobacterium tuberculosis viability, rifampin resistance, and pathogenesis.

Authors:  Leslie A Weiss; Phillip G Harrison; Bryce E Nickels; Michael S Glickman; Elizabeth A Campbell; Seth A Darst; Christina L Stallings
Journal:  J Bacteriol       Date:  2012-08-17       Impact factor: 3.490

8.  CarD integrates three functional modules to promote efficient transcription, antibiotic tolerance, and pathogenesis in mycobacteria.

Authors:  Ashley L Garner; Leslie A Weiss; Ana Ruiz Manzano; Eric A Galburt; Christina L Stallings
Journal:  Mol Microbiol       Date:  2014-07-16       Impact factor: 3.501

9.  EmbA is an essential arabinosyltransferase in Mycobacterium tuberculosis.

Authors:  Anita G Amin; Renan Goude; Libin Shi; Jian Zhang; Delphi Chatterjee; Tanya Parish
Journal:  Microbiology (Reading)       Date:  2008-01       Impact factor: 2.777

10.  Comparative genomic analysis of mycobacteriophage Tweety: evolutionary insights and construction of compatible site-specific integration vectors for mycobacteria.

Authors:  Thuy T Pham; Deborah Jacobs-Sera; Marisa L Pedulla; Roger W Hendrix; Graham F Hatfull
Journal:  Microbiology (Reading)       Date:  2007-08       Impact factor: 2.777

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.